Publications by Patrick Marquis

Peer-reviewed publications

  1. Cleanthous S, Cano S, Kinter E, Marquis P, Petrillo J, You X, et al. Measuring the impact of multiple sclerosis: Enhancing the measurement performance of the Multiple Sclerosis Impact Scale (MSIS-29) using Rasch Measurement Theory (RMT). Multiple Sclerosis Journal – Experimental, Translational and Clinical. 2017;3(3).
  2. Powers JH, 3rd, Patrick DL, Walton MK, Marquis P, Cano S, Hobart J, et al. Clinician-Reported Outcome Assessments of Treatment Benefit: Report of the ISPOR Clinical Outcome Assessment Emerging Good Practices Task Force. Value Health. 2017;20(1):2-14.
  3. Walton MK, Powers JH, 3rd, Hobart J, Patrick D, Marquis P, Vamvakas S, et al. Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force. Value Health. 2015;18(6):741-52.
  4. Marquis P, Lasch KE, Delgado-Herrera L, Kothari S, Lembo A, Lademacher C, et al. Qualitative development of a patient-reported outcome symptom measure in diarrhea-predominant irritable bowel syndrome. Clinical and translational gastroenterology. 2014;5:e59.
  5. Marquis P, Caron M, Emery M-P, Scott J, Arnould B. The Role of Health-Related Quality of Life Data in the Drug Approval Processes in the US and Europe: A Review of Guidance Documents and Authorizations of Medicinal Products from 2006 to 2010. Pharm Med. 2011;25(3):147-60.
  6. Lasch KE, Marquis P, Vigneux M, Abetz L, Arnould B, Bayliss M, et al. PRO development: rigorous qualitative research as the crucial foundation. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2010;19(8):1087-96.
  7. Meunier PJ, Roux C, Ortolani S, Diaz-Curiel M, Compston J, Marquis P, et al. Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2009;20(10):1663-73.
  8. Marquis P, Roux C, de la Loge C, Diaz-Curiel M, Cormier C, Isaia G, et al. Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2008;19(4):503-10.
  9. Marquis P, Arnould B, Acquadro C, Roberts WM. Patient-Reported Outcomes and Health-Related Quality of Life in effectiveness studies: pros and cons. Drug Development Research. 2006;67(3):193-201.
  10. Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scandinavian journal of gastroenterology. 2005;40(5):540-51.
  11. Hasle-Pham E, Arnould B, Spath HM, Follet A, Duru G, Marquis P. Role of clinical, patient-reported outcome and medico-economic studies in the public hospital drug formulary decision-making process: results of a European survey. Health policy (Amsterdam, Netherlands). 2005;71(2):205-12.
  12. DiBenedetti DB, Gondek K, Sagnier PP, Kubin M, Marquis P, Keininger D, et al. The treatment satisfaction scale: a multidimensional instrument for the assessment of treatment satisfaction for erectile dysfunction patients and their partners. European urology. 2005;48(3):503-11.
  13. de la Loge C, Sullivan K, Pinkney R, Marquis P, Roux C, Meunier PJ. Cross-cultural validation and analysis of responsiveness of the QUALIOST: QUAlity of Life questionnaire In OSTeoporosis. Health and quality of life outcomes. 2005;3:69.
  14. Marquis P, Chassany O, Abetz L. A comprehensive strategy for the interpretation of quality-of-life data based on existing methods. Value Health. 2004;7(1):93-104.
  15. Evans CJ, Trudeau E, Mertzanis P, Marquis P, Pena BM, Wong J, et al. Development and validation of the Pain Treatment Satisfaction Scale (PTSS): a patient satisfaction questionnaire for use in patients with chronic or acute pain. Pain. 2004;112(3):254-66.
  16. de La Loge C, Trudeau E, Marquis P, Revicki DA, Rentz AM, Stanghellini V, et al. Responsiveness and interpretation of a quality of life questionnaire specific to upper gastrointestinal disorders. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2004;2(9):778-86.
  17. de la Loge C, Trudeau E, Marquis P, Kahrilas P, Stanghellini V, Talley NJ, et al. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2004;13(10):1751-62.
  18. Marquis P, Marrel A, Jambon B. Quality of life in patients with stomas: the Montreux Study. Ostomy/wound management. 2003;49(2):48-55.
  19. Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, et al. Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health. 2003;6(5):522-31.
  20. Symonds T, Berzon R, Marquis P, Rummans TA. The clinical significance of quality-of-life results: practical considerations for specific audiences. Mayo Clinic proceedings. 2002;77(6):572-83.
  21. Lamping DL, Schroter S, Marquis P, Marrel A, Duprat-Lomon I, Sagnier PP. The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. Chest. 2002;122(3):920-9.
  22. Chassany O, Sagnier PP, Marquis P, Fullerton S, Aaronson N, For the ERIQA group. Patient-reported outcomes: the example of health-related quality of life – A European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Information Journal. 2002;36(1):209-38.
  23. Pigot F, Castinel A, Juguet F, Marrel A, Deroche C, Marquis P. [Quality of life, symptoms of dyschezia, and anatomy after correction of rectal motility disorder]. Gastroenterologie clinique et biologique. 2001;25(2):154-60.
  24. Marquis P, Trudeau E. Quality of life and patient satisfaction: two important aspects in asthma therapy. Current opinion in pulmonary medicine. 2001;7 Suppl 1:S18-20.
  25. Marquis P, Marrel A. Reproducibility and clinical and concurrent validity of the MSF-4: a four-item male sexual function questionnaire for patients with benign prostatic hyperplasia. Value Health. 2001;4(4):335-43.
  26. Marquis P, Le Gal M, Francillon A, Andre-Fouet X. [Quality of life and angina pectoris. Comparison of the effects of 2 nitrate derivatives administered discontinuously: transdermal 10 mg nitroglycerine patch (12 hours) and long-acting oral 40 mg isosorbide-5-mononitrate (once a day)]. Annales de cardiologie et d’angeiologie. 2001;50(6):340-50.
  27. Marquis P, Comte S, Lehert P. International validation of the CLAU-S quality-of-life questionnaire for use in patients with intermittent claudication. PharmacoEconomics. 2001;19(6):667-77.
  28. Marquis P, Cialdella P, De la Loge C. Development and validation of a specific quality of life module in post-menopausal women with osteoporosis: the QUALIOST. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2001;10(6):555-66.
  29. Marquis P. Health-related quality of life (HRQL). Value Health. 2001;4(4):344-5.
  30. Levenstein S, Li Z, Almer S, Barbosa A, Marquis P, Moser G, et al. Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. The American journal of gastroenterology. 2001;96(6):1822-30.
  31. Jambon B, Marquis P, Burke LB, Kind P, Kline Leidy N, Barofsky I, et al. A decisive step towards the recognition of patient reported outcomes in clinical trials. Quality of Life Newsletter. 2001;26:24-5.
  32. Costa P, Perrouin-Verbe B, Colvez A, Didier J, Marquis P, Marrel A, et al. Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen. European urology. 2001;39(1):107-13.
  33. Blondel-Kucharski F, Chircop C, Marquis P, Cortot A, Baron F, Gendre JP, et al. Health-related quality of life in Crohn’s disease: a prospective longitudinal study in 231 patients. The American journal of gastroenterology. 2001;96(10):2915-20.
  34. Wool C, Cerutti R, Marquis P, Cialdella P, Hervie C. Psychometric validation of two Italian quality of life questionnaires in menopausal women. Maturitas. 2000;35(2):129-42.
  35. Sacher-Huvelin S, Gournay J, Amouretti M, Marquis P, Bruley Des Varannes S, Galmiche JP. [Acid-sensitive esophagus: natural history and effect on the quality of life. Comparison with gastroesophageal reflux]. Gastroenterologie clinique et biologique. 2000;24(10):911-6.
  36. Raymond JM, Marquis P, Bechade D, Smith D, Mathiex Fortunet H, Poynard T, et al. [Assessment of quality of life of patients with gastroesophageal reflux. Elaboration and validation of a specific questionnaire]. Gastroenterologie clinique et biologique. 1999;23(1):32-9.
  37. Patrick DL, Martin ML, Bushnell DM, Marquis P, Andrejasich CM, Buesching DP. Cultural adaptation of a quality-of-life measure for urinary incontinence. European urology. 1999;36(5):427-35.
  38. Louis E, Marquis P, Nalet B. [How does one evaluate the severity of gastroesophageal reflux and what are the therapeutic objectives?]. Revue medicale de Bruxelles. 1999;20(2):A114-5.
  39. Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scandinavian journal of gastroenterology Supplement. 1999;231:48-54.
  40. Chassany O, Marquis P, Scherrer B, Read NW, Finger T, Bergmann JF, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut. 1999;44(4):527-33.
  41. Selke B, Marquis P, Lebrun T. [Socioeconomic and quality of life repercussions of arterial hypertension]. Drugs. 1998;56 Suppl 2:45-53.
  42. Marquis P, Lecasble M, Passa P. [Quality of life of patient with peripheral arterial obliterative disease treated with ifenprodil tartrate. Results of an ARTEMIS study]. Drugs. 1998;56 Suppl 3:37-48.
  43. Marquis P. [Evaluation of the impact of peripheral obliterative arteriopathy on quality of life]. Drugs. 1998;56 Suppl 3:25-35.
  44. Berdeaux G, Hervie C, Smajda C, Marquis P. Parental quality of life and recurrent ENT infections in their children: development of a questionnaire. Rhinitis Survey Group. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 1998;7(6):501-12.
  45. Amarenco G, Marquis P, McCarthy C, Richard F. [Quality of life of women with stress urinary incontinence with or without pollakiuria]. Presse medicale (Paris, France : 1983). 1998;27(1):5-10.
  46. Yazdanpanah Y, Klein O, Gambiez L, Baron P, Desreumaux P, Marquis P, et al. Impact of surgery on quality of life in Crohn’s disease. The American journal of gastroenterology. 1997;92(10):1897-900.
  47. Marquis P, Amarenco G, Sapede C, Josserand F, McCarthy C, Zerbib M, et al. [Elaboration and validation of a specific quality of life questionnaire for urination urgency in women]. Progres en urologie : journal de l’Association francaise d’urologie et de la Societe francaise d’urologie. 1997;7(1):56-63.
  48. Calais Da Silva F, Marquis P, Deschaseaux P, Gineste JL, Cauquil J, Patrick DL. Relative importance of sexuality and quality of life in patients with prostatic symptoms. Results of an international study. European urology. 1997;31(3):272-80.
  49. Marquis P. Sleep disturbance. A component of health status. PharmacoEconomics. 1996;10 Suppl 1:25-8.
  50. Colombel JF, Yazdanpanah Y, Laurent F, Houcke P, Delas N, Marquis P. [Quality of life in chronic inflammatory bowel diseases. Validation of a questionnaire and first French data]. Gastroenterologie clinique et biologique. 1996;20(12):1071-7.
  51. Bousquet J, Duchateau J, Pignat JC, Fayol C, Marquis P, Mariz S, et al. Improvement of quality of life by treatment with cetirizine in patients with perennial allergic rhinitis as determined by a French version of the SF-36 questionnaire. The Journal of allergy and clinical immunology. 1996;98(2):309-16.
  52. Marquis P, Fayol C, Joire JE, Leplege A. Psychometric properties of a specific quality of life questionnaire in angina pectoris patients. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 1995;4(6):540-6.
  53. Marquis P, Fayol C, Joire JE. Clinical validation of a quality of life questionnaire in angina pectoris patients. European heart journal. 1995;16(11):1554-60.
  54. Leplege A, Mesbah M, Marquis P. [Preliminary analysis of the psychometric properties of the French version of an international questionnaire measuring the quality of life: the MOS SF-36 (version 1.1)]. Revue d’epidemiologie et de sante publique. 1995;43(4):371-9.
  55. Rampal P, Martin C, Marquis P, Ware JE, Bonfils S. A quality of life study in five hundred and eighty-one duodenal ulcer patients. Maintenance versus intermittent treatment with nizatidine. Scandinavian journal of gastroenterology Supplement. 1994;206:44-51.
  56. Martin C, Marquis P, Bonfils S. A ‘quality of life questionnaire’ adapted to duodenal ulcer therapeutic trials. Scandinavian journal of gastroenterology Supplement. 1994;206:40-3.
  57. Marquis P, Fayol C, McCarthy C, Fiessinger JN. [Measurement of quality of life in intermittent claudication. Clinical validation of a questionnaire]. Presse medicale (Paris, France : 1983). 1994;23(28):1288-92.
  58. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin B. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. The Journal of allergy and clinical immunology. 1994;94(2 Pt 1):182-8.

 

Book Chapters

  1. Marquis P, Keininger D, Acquadro C, De La Loge C. Translating and evaluating questionnaires: cultural issues for international research. In: Fayers P, Hays R, editors. Assessing Quality of Life in Clinical Trials. New York: Oxford University Press; 2005. p. 77-93.
  2. Marquis P. Quality of life assessment in neurogenic bladder. In: Corcos J, Schick E, editors. Textbook of Neurogenic Bladder: Adults and Children. London: Martin Dunitz Ltd; 2004. p. 365-72.
  3. Marquis P, Lademacher C, Rozenbaum H. Once a week transdermal estrogen -quality of life improvement in long-term replacement therapy: newest findings. In: Paoletti R, Crosignani PG, Kenemans P, Samsioe G, Soma M, Jackson AS, editors. Women’s Health and Menopause: Risk Reduction Strategies -Improved Quality of Health: Kluwer Academic Publishers; 1999. p. 183-8.
  4. Amarenco G, Marquis P, Jacquetin B, Richard F. Evaluation de la perturbation de la qualité de vie au cours des hyperactivités vésicales. Evaluation de l’hyperactivité. Paris: Elsevier; 1998. p. 61-6.
  5. Acquadro C, Jambon B, Ellis D, Marquis P. Language and Translation Issues. In: Spilker B, editor. Quality of Life and Pharmacoeconomics in Clinical Trials. Philadelphia: Lippincott-Raven Publishers; 1996. p. 575-85.